baber/WOPTO huggingface dataset:
Patent NZ-504368-A (NZ)
Title: Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
Inventor: DURING KLAUS
IPC: A01N63/00
Filed: 1998-10-31
Abstract: Lysozym-analogous proteins and peptides having an anti-microbial activity, their production and recombinant proteins which contain at least the amino acids 126-141 or 143-155 of the T4 lysozyme. These proteins and peptides are recombinantly modified or modified by mutations only as far as their main properties are preserved, especially the anti-microbial properties of the T4 lysozyme and except for the muramidase activity. These proteins and peptides are produced from their coding genes, wherein their production comprises carrying out their bio-synthesis in prokaryotic and eukaryotic organisms as well as using chemically-synthesised proteins or peptides. These proteins and peptides are useful as medical active agents, as food additives and animal-food additives or as other in vivo and in vitro anti-microbial protection materials or as exogenic proteins in transgenic organisms.
Patent NZ-504482-A (NZ)
Title: Aryl fused azapolycyclic compounds and pharmaceuticals thereof which bind to neuronal nicotinic acetylcholine specific recpetor sites and are useful for modulating cholinergic function
Inventor: COE JOTHAM WADSWORTH
IPC: A61P25/16
Filed: 1998-11-13
Abstract: Compounds of formula (I) and their pharmaceutically acceptable salts, wherein R1, R2, R3 and n are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.
Patent NZ-506478-A (NZ)
Title: Trans-somatics with gene transfer into mammary epithelial cells
Inventor: GAVORA JAN S
IPC: A61K48/00
Filed: 1998-06-25
Abstract: A method of incorporating a DNA sequence into the secretory cells of the mammary gland of a non-human mammal comprising introducing a vector containing the gene of interest into a packaging cell line, preparing a solution containing this cell line and delivering the solution to the mammary gland resulting in a trans-somatic animal.
Patent NZ-510769-A (NZ)
Title: Antibodies for judging possibility of the onset of bovine leukemia
Inventor: AIDA YOKO
IPC: C12N15/02
Filed: 1999-09-07
Abstract: Use of the c143 monoclonal antibody to detect the potential onset of bovine leukemia in a bovine.
Patent NZ-512103-A (NZ)
Title: Hapten-carrier conjugates for treating and preventing nicotine addiction
Inventor: ENNIFAR SOFIANE
IPC: A61K47/48
Filed: 1999-12-01
Abstract: Disclosed  are  hapten-carrier conjugates  capable  of inducing  the  production  of  antibodies,  in  vivo,  which specifically bind to nicotine. These conjugates  comprise  a nicotine   hapten  conjugated  to  an  immunogenic   carrier protein, as shown in formula (1), wherein: M is 1-2500 N is 0-12 Y is 1-12 X is selected from the group consisting of NH-CO, CO-NH, CO- NH-NH, NH-NH-CO, NH-CO-NH, CO-NH-NH-CO, and S-S; Y is selected from the group consisting of NH-CO, CO-NH, CO- NH-NH, NH-NH-CO, NH-CO-NH, CO-NH-NH-CO, and S-S, and the -(CH2)n -X-(CH2)y -Y- moiety is bonded to the 3', 4' or 5' position of nicotine. The  conjugates  preserve the chirality of nicotine  in  its native  (S)-(-)  state, and have good stability  properties. The conjugates are useful in formulating vaccines for active immunization  that  are used to prevent and  treat  nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive  immunization. These   antibodies  are  administered  for  prevention   and treatment of nicotine addiction.
Patent NZ-513571-A (NZ)
Title: Automated transcription system and method using two speech converting instances and computer-assisted correction
Inventor: QIN CHARLES
IPC: G10L15/28
Filed: 2000-02-18
Abstract: A system for substantially automating transcription services for one or more voice users comprises: means for receiving a voice dictation file from a current user with the current user being one of the one or more voice users; first means for automatically converting the voice dictation file into a first written text with the first automatic conversion means having a first set of conversion variables; second means for automatically converting the voice dictation file into a second written text with the second automatic converting means having a second set of conversion variables and the first and second sets of conversion variables having at least one difference and means for manually editing a copy of the first and second written texts to create a verbatim text of the voice dictation file.
Patent NZ-514451-A (NZ)
Title: A power socket with a cam connected to a switch to prevent the "on" without proper insertion of the corresponding male plug to prevent electric shocks or childproofing an electric socket
Inventor: WOOF GRAHAM
IPC: H01R13/447
Filed: 2001-09-26
Abstract: An electrical power outlet (10) includes a socket portion (12) arranged to receive an electrical plug (13), a switching device (14), a first actuator (18) operatively associated with the socket portion (12) and with the switching device (14), and a second actuator (54) operatively associated with the socket portion (12) and with the switching device (14). The first actuator (18) is arranged to prevent the switching device (14) from moving to an on state when a plug (13) is not received in the socket portion (12). The second actuator (54) is movable between an unlocked position wherein a plug (13) is removable from the socket portion (12) and a locked position wherein a plug (12) is not removable from the socket portion (12). The switching device (14) cooperates with the second actuator (54) so as to cause the second actuator (54) to move to the locked position when the switching device (14) moves to the on state.
Patent NZ-529148-A (NZ)
Title: A food supplement containing essential fatty acids and products therefrom
Inventor: STEWART JAMES F
IPC: A23L13/00
Filed: 2002-04-23
Abstract: Disclosed is a livestock feed comprising: a) a feed supplement enriched with one or more fatty acids selected from the group consisting of omega 3 fatty acids and omega 6 fatty acids; b) a natural ingredient selected from the group consisting of talc, clay and mixtures thereof capable of acting as a by-pass ingredient; and c) a plant food source comprising omega 3 fatty acids, wherein said plant food source is selected from the groups consisting of ground sprouted flax, dried sprouted flax, and a mixture thereof.
Patent NZ-533987-A (NZ)
Title: Uses of mammalian cytokine; agonists and antagonists for modulating antigen presenting cell priming of T cells
Inventor: DE WAAL MALEFYT RENE
IPC: C12N5/0784
Filed: 2003-01-30
Abstract: Provided are methods of making medicaments for use in modulating dendritic cell activity employing agonists or antagonists of TSLP/IL50 or TSLP/IL50 receptors (TSLP/IL50R) for modulating antigen presenting cell (APC) priming of T cells. Also provided are ex vivo methods of treating autologous or allogeneic antigen presenting cells from a subject suffering from an immune disorder comprising administration of agonists or antagonists of TSLP/IL50 or TSLP/IL50 receptors (TSLP/IL50R).
Patent NZ-534545-A (NZ)
Title: EIF4E gene mutations and potyvirus resistance
Inventor: CARANTA CAROLE
IPC: C12Q1/68
Filed: 2003-02-07
Abstract: Disclosed is a method for selecting potyvirus-resistant plants, comprising the detection in the plants to be tested: - of the presence or of the absence of an eIF4E protein (hereinafter referred to as: "wild-type eIF4E protein") comprising a region defined by sequence (I) below DX1X2X3X4KSX5QX6AWGSSX7RX8X9YTFSX10VEX11FWX12X13YNNIHX14PSKLX15X16GAD in which: - X1, X2, X3, X4, X6, X7, X8, X9, X10, X11, X12, X13, X15 and X16 each represent a neutral amino acid; - X5 and X14 represent a basic amino acid; - X11 represents an acidic amino acid; - D, K, S, Q, A, W, G, R, Y, T, F, V, E, N, I, H, P and L have their usual 1-letter code meaning, or of a nucleotide sequence encoding said protein; - of the presence or of the absence of a mutant eIF4E protein comprising a region derived from that defined by sequence (I) by substitution of at least one neutral amino acid of said sequence (I) with a charged amino acid, and/or substitution of at least one charged amino acid of said sequence (I) with a neutral amino acid or an amino acid having an opposite charge, or of a sequence encoding said protein; - and the selection of the plants in which a mutant eIF4E protein or a nucleotide sequence encoding said protein is detected, and in which no wild-type eIF4E protein or sequence encoding said protein is detected.
Patent NZ-535651-A (NZ)
Title: Call category for a call that terminates at announcement server component
Inventor: BEAUFORD KEVIN D
IPC: H04W68/00
Filed: 2004-09-29
Abstract: An apparatus comprises a call control component that sets a call category for a call to indicate that the call terminates at an announcement server component prior to connection with a called communication device. Upon receipt of an answer message from the announcement server component, the call control component drops the answer message based on the call category. The call can terminate at the announcement server component and the called communication device and the call control component accepts an answer message from the called communication device. The call control component can drop the answer message from the announcement server component to prevent an initiation of billing for the call based on the answer message from the announcement server component and the call control component initiates the billing for the call upon receipt of the answer message from the called communication device. The call control component can receives the call and sends a signaling message associated with the call to the announcement server component to involve the announcement server component on the call and the announcement server component plays an announcement for a calling communication device of the call and sends the answer message to the call control component, wherein the call control component determines to not process the answer message from the announcement server component based on the call category.
Patent NZ-536906-A (NZ)
Title: A handle mounting assembly
Inventor: BLANCH DAVID GARFIELD
IPC: E05B3/00
Filed: 2004-12-01
Abstract: A door handle assembly has a specially designed but simple mechanism to enable the "hand" of the assembly to be easily changed without needing to remove screws or clips which can be lost. Instead an internal clip can be loosened to enable the hand to be changed. The clip sits on a threaded rod which is captured in the assembly and cannot be lost. The rod has a screw head accessible through a small hole in the assembly to enable the rod to be rotated from outside the assembly by a screwdriver.
Patent NZ-539249-A (NZ)
Title: Connector systems for building materials
Inventor: WALKER RICHARD ALAN
IPC: E04B1/61
Filed: 2003-10-09
Abstract: A connector (15) for connecting modules together comprises a plastics connector member (16), an expander rod (17) and a threaded expander rod displacer (18). The connector member (16) has spaced dovetail style enlargements (19) on one side and a full length dovetail enlargement (20) on the other side. The connector member (16) is designed to slide in the confronting slots with the wasted sections (21) of the expander (17) located inside each of the sections (19). Once in position the threaded expander rod displacer (18) is used to axially displace the expander (17) to force the enlarged sections of the expander (17) into the sections (19) thus engaging the slot and at the same time biassing the modules together.
Patent NZ-539796-A (NZ)
Title: Peritoneal dialysis method comprising adenosine triphosphate
Inventor: KIRIBAYASHI KEI
IPC: A61P29/00
Filed: 2003-11-20
Abstract: Adenosine triphosphate can be used in the manufacture of a peritoneal dialysate, wherein the level of ATP in the diasylate is 10 to 5,000 uM. ATP can also be used in the manufacture of a therapeutic agent for peritoneal cell injury, such as that caused by glucose.
Patent NZ-540969-A (NZ)
Title: 4-cyclopentyl resorcinol monohydrate as a depigmentation agent
Inventor: PROCTER MARTIN JAMES
IPC: A61K31/05
Filed: 2004-01-30
Abstract: Disclosed is 4-cyclopentyl resorcinol monohydrate wherein the molar ratio of water to 4-cyclopentyl resorcinol is from 0.7:1 to 1.4:1. Also disclosed is a crystalline polymorph of the monohydrate.
Patent NZ-542280-A (NZ)
Title: A film having a liquid absorbed therein
Inventor: SAMUELS BRIAN R
IPC: C08J7/056
Filed: 2004-03-11
Abstract: Disclosed is a film having a liquid at least partially absorbed therein, wherein the liquid has been applied to a surface of the film and prior to application of the liquid to the surface, the surface has been subjected to a surface activation treatment for increasing the amount of liquid that can be absorbed such that the surface has a surface energy of at least about 50 dynes.
Patent NZ-543299-A (NZ)
Title: Transesterification method of preparing biodiesel from vegetable oil and meat fat
Inventor: BEHZADI SAM
Filed: 2005-10-27
Abstract: A process for preparing alkyl ester via a transesterification reaction from a vegetable oil and/or meat fat containing triglycerides is disclosed, which comprises reacting an atomised feed of vegetable oil and/or meat fat (" the atomised feed") with gaseous alcohol in a reaction vessel. This process is suitable for continuous production of biodiesel.
Patent NZ-550703-A (NZ)
Title: Operator bar for stud and plate framing nailer table
Inventor: YOUNG GRAME LAWRENCE
Filed: 2006-10-20
Abstract: An apparatus for the fabrication of timber wall frames for pre-fabricated buildings, in which studs, plates and braces are nailed together, is disclosed. The apparatus includes at least one nail gun (mounted so as to be able to move vertically in relation to the horizontal plane of the frame), a controller and a control input device operated by a user.
Patent NZ-552594-A (NZ)
Title: Wood gasification apparatus
Inventor: SMITH DAVID NIXON
IPC: C07C1/00
Filed: 2005-06-30
Abstract: An apparatus (10) for converting particulate materials into a gas is disclosed. The apparatus (10) including a housing (12) with an inlet and an outlet, and a rotatable auger (14) mounted in the housing (12). The auger (14) has surfaces defining at least one spiral channel. The auger (14) rotates to propel particulate material from a housing (12) inlet toward a housing (12) outlet and is adapted to frictionally heat the particulate to a temperature, which is sufficient to convert at least a portion of particulate material into a gas.
Patent NZ-560806-A (NZ)
Title: System and method for maintaining air inflatable mattress configuration
Inventor: PHILLIPS BRUCE L
Filed: 2006-02-16
Abstract: A patient support system to control support of a patient is provided. The system comprises a mattress having a number of inflatable chambers, a number of transmitters positioned proximal a surface of the inflatable chambers, a number of receivers positioned proximal a surface of the inflatable chambers, and a network having a number of controller area network nodes in communication with each other and to the transmitters and receivers.
Patent NZ-567013-A (NZ)
Title: A hinge
Filed: 2008-03-27
Abstract: A hinge assembly ( 1 ) is disclosed to pivotally attach a door to a door jamb having a first hinge half ( 5 ) to be attached to the jamb and including a passage ( 10 ) extending generally vertically. The passage ( 10 ) has a threaded length ( 12 ). A second hinge half ( 15 ) is to be attached to the door and includes a passage ( 20 ) extending generally vertically and to be located above and axially aligned with the first hinge half passage. A pivot pin ( not shown ) is to be located in both passages to pivotally attach the door to the jamb.
Patent NZ-567413-A (NZ)
Title: Easy-open/reclosable bag and package
Inventor: SHAH GAUTUM P
IPC: B65D33/18
Filed: 2008-04-14
Abstract: An easy-open/recloseable thermoplastic bag 63 comprising: a) a first wall 16 having an outer surface and an inner surface; b) a second wall having an outer surface and an inner surface; c) a bottom portion 65 connecting the first and second walls; d) a first side seal 75; e) a second side seal 76; and f) a bag mouth 27; wherein the first wall 16 comprises, at one end thereof distal from the bottom portion 65, a first folded edge portion comprising i) a first segment, ii) a fold, iii) a second segment, and iv) a pressure sensitive adhesive 24 disposed between and in contact with the first and second segment of the first folded edge portion; wherein the outer surface of the first wall 16 comprises an easy-open sealant; wherein the outer surface of the second wall comprises an easy-open sealant or a regular sealant; and wherein the inner surface of the first wall 16, and the inner surface of the second wall, each comprises a regular sealant.
Patent NZ-570696-A (NZ)
Title: Aggregate spreader
Inventor: HUNT ANDREW MICHAEL
IPC: E01C19/12
Filed: 2008-08-20
Abstract: Disclosed is an aggregate spreading apparatus and a method of controlling the spread width of aggregate. The spreading apparatus includes an aggregate receiving means adapted to receive aggregate from an aggregate source. The aggregate receiving means has an outlet means through which aggregate can pass. The apparatus includes a flexible member with an aperture; the flexible member extends across the outlet means. The apparatus further includes a flexible member positioning means for adjusting the position of the flexible member and thereby adjusting the position of the aperture relative to the outlet means.
Patent NZ-572804-A (NZ)
Title: Patches for testing sensitivity to an allergen
Inventor: DUPONT CHRISTOPHE
IPC: A61B17/00
Filed: 2007-04-24
Abstract: A ready-to-use skin patch (1) is disclosed. The patch has a support (2) with electrostatic properties. A periphery of the support is coated with an adhesive material (3), and all or part of the non-adhesive surface of the support is covered with at least one biologically active substance (5). The biologically active substance is in the form of particles that adhere to the non-adhesive part of the support by electrostatic forces created at manufacture. A method of manufacturing the patch including how to create the electrostatic properties of the support is also disclosed.
Patent NZ-575886-A (NZ)
Title: Serine or cysteine proteinase inhibitor clade H (SERPHINH1) as a marker for detection of gastric cancer
Inventor: GUILFORD PARRY JOHN
IPC: C12Q1/68
Filed: 2004-07-16
Abstract: Disclosed is a method for detecting gastric cancer, comprising: (a) providing a biological sample; and (b) detecting over-expression of a GTM family member in said sample, wherein the GTM family member is serine or cysteine proteinase inhibitor clade H ("SERPINH1").
Patent NZ-583049-A (NZ)
Title: Method for the production of amino crotonyl compounds and the dimaleate salt of 4-[(3-chloro-4-fluorophenyl)amino]-6-{ [4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino} -7-((S)-tetrahydrofuran-3-yloxy)-quinazoline
Inventor: RALL WERNER
IPC: A61K31/505
Filed: 2004-10-12
Abstract: Disclosed is a process for preparing the dimaleate of 4-[(3-chloro-4-fluorophenyl)amino]-6{ [4-(N, N-dimethylamino)-1-oxo-2-buten-1-yl]amino} -7-((S)-tetrahydrofuran-3-yloxy)-quinazoline, comprising the following step: converting 4-[(3-chloro-4-fluorophenyl)amino]-6-{ [4-(N,N-dimethylamino)-1oxo-2-buten-1-yl]amino} -7-((S)-tetrahydrofuran-3-yloxy)-quinazoline into the dimaleate by reacting with maleic acid in a suitable solvent, with heating. Also disclosed is the compound 4-[(3-Chloro-4-fluorophenyl)amino]-6-{ [4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino} -7-((S)-tetrahydrofuran-3-yloxy)-quinazoline dimaleate; a pharamacutical composistion containing the compound and the use of the compound for preparing a pharmaceutical composition which is suitable for the treatment of benign or malignant tumours, for preventing and treating diseases of the respiratory tract and lungs as well as for treating diseases of the gastro-intestinal tract and the bile duct and gall bladder.
Patent NZ-583257-A (NZ)
Title: Constructing record of tool vibrations over time and allowing or disallowing a user to operate the tool based on the record and a user device
Inventor: COSTE JEAN-PIERRE
IPC: G07C3/08
Filed: 2008-08-07
Abstract: Disclosed is a system for recording the vibration history of, and controlling, a tool (1). The system is intended to block the tool's operation for at least one operator bearing a badge (2) when the operator's authorised working time of the tool (1) is over. The system is comprised of the operator badge (2), which includes a storage memory (23) for the working time carried out by the operator, and a communication unit (21). The system is also comprised of the tool (1), which includes energy supply means (10), actuating means (8), an acceleration sensor (9) and a unit for control and vibration recording (7). The unit for control and vibration recording (7) includes a communication module (13), arranged to exchange data with the operator badge (2), means for blocking the tool's operation (11), and a terminal (3) for driving the tool (1). The terminal (3) for driving the tool (1) includes a communication unit (31) and means for blocking the tool's operation (32).
Patent NZ-595481-A (NZ)
Title: Aminothiazole molecules and pesticidal compositions comprising aminothiazoles
Inventor: ROSS RONALD
IPC: A01N43/78
Filed: 2010-05-04
Abstract: 595481 Provided are aminothiazole derivative molecules of formula (I) and processes to produce these molecules, where the variables are described herein. These aminothiazole derivative molecules are useful as pesticides (e.g., acaricides, insecticides, molluscicides, and nematicides) to control pests. Also provided are compositions and processes for using compounds such as 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-oxa-1-azaspiro[4,5]dec-3-en-2-one, 4-[[(6-chloro-3-pyridinyl)methyl]cyclopropylamino]-2(5H)-furanone, 4-[4-chlorophenyl-(2-butylidine-hydrazono)methyl]phenyl mesylate and the aminothiazole derivative molecules for controlling pests.
Patent NZ-595780-A (NZ)
Title: Chromane derivatives as trpv3 modulators
Inventor: LINGAM V
IPC: C07D311/04
Filed: 2009-05-19
Abstract: Disclosed herein are chromane derivatives of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as Transient Receptor Potential Vanilloid 3 (TRPV3) modulators and as such are useful in the treatment of pain, acute pain, chronic pain, nociceptive pain, neuropathic pain, post-operative pain, dental pain, cancer pain, cardiac pain arising from an ischemic myocardium, pain due to migraine, arthralgia, neuropathies, neuralgia, trigeminal neuralgia nerve injury, diabetic neuropathy, neurodegeneration, retinopathy, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, urinary incontinence, vulvodynia, gastrointestinal disorders such as irritable bowel syndrome. Examples of particularly preferred compounds include: 2-(6-Chloro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)-N-(2-methoxyphenyl) acetamide, 2-(6-Chloro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)-N-(2-cyclopentyloxy-3-methoxybenzyl)acetamide, 2-(6-Chloro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)-N-1-(4-methoxynaphthylmethyl)acetamide, 2-(6-Chloro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)-N-[(4-methoxydibenzo[b,d]furan-1-yl) methyl]acetamide, 2-(6-Chloro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)-N-[(1S)-1-phenylethyl]acetamide, N-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-2-(6-fluoro-3,4-dihydrospiro[chromene-2,1'-cyclobutan]-4-yl)acetamide.